| 000 | 01877 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250515225416.0 | ||
| 264 | 0 | _c20100914 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2010.132 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPratz, K W | |
| 245 | 0 | 0 |
_aA pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias. _h[electronic resource] |
| 260 |
_bLeukemia _cAug 2010 |
||
| 300 |
_a1437-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aBenzenesulfonates _xpharmacokinetics |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xblood |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 |
_aPyridines _xpharmacokinetics |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 |
_afms-Like Tyrosine Kinase 3 _xantagonists & inhibitors |
| 700 | 1 | _aCho, E | |
| 700 | 1 | _aLevis, M J | |
| 700 | 1 | _aKarp, J E | |
| 700 | 1 | _aGore, S D | |
| 700 | 1 | _aMcDevitt, M | |
| 700 | 1 | _aStine, A | |
| 700 | 1 | _aZhao, M | |
| 700 | 1 | _aBaker, S D | |
| 700 | 1 | _aCarducci, M A | |
| 700 | 1 | _aWright, J J | |
| 700 | 1 | _aRudek, M A | |
| 700 | 1 | _aSmith, B D | |
| 773 | 0 |
_tLeukemia _gvol. 24 _gno. 8 _gp. 1437-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2010.132 _zAvailable from publisher's website |
| 999 |
_c19885199 _d19885199 |
||